Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial is a research paper published in Nature Medicine (2022). On theSindex it has a DataRank of 3.6. It has been cited 165 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.767
From this paper's citation signal
Citation Network Contribution
2.8
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
NIAID NIH HHS
Grant: 75N93021C00014
NIAID NIH HHS
Grant: R01 AI145870
Intramural NIH HHS
Grant: Z99 AI999999
NIAID NIH HHS
Grant: P01 AI097092
NIAID NIH HHS
Grant: 75N93019C00051
National Institutes of Health
Grant: 5P01AI097092-04
Monoclonal Antibody Technology Core
National Institutes of Health
Grant: 3R01AI145870-02S1
Evaluation of the FcgR mechanisms in the antibody-dependent enhancement of SARS-CoV-2 infection
FWCI
21.69
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Expression of TFRC helps to improve the antineoplastic effect of Ara-C on AML cells through a targeted delivery carrier
Additional file 1 of Expression of TFRC helps to improve the antineoplastic effect of Ara-C on AML cells through a targeted delivery carrier
Additional file 1 of Laser-activable murine ferritin nanocage for chemo-photothermal therapy of colorectal cancer
Additional file 1 of Laser-activable murine ferritin nanocage for chemo-photothermal therapy of colorectal cancer